Compositions including combinations of class I histone deacetylase (HDAC) inhibitors and programmed cell death protein 1 (PD-1) inhibitors for enhancing antitumor activity are disclosed. Further disclosed are methods of administering these compositions as immunotherapies for suppressing regulatory T cells in renal cell carcinoma.
Medicine Doctors
Dr. Roberto Pili, Buffalo NY - MD (Doctor of Medicine)
IU Health PhysiciansIndiana University Simon Cancer Center 535 Barnhill Dr RM RT473, Indianapolis, IN 46202 3179440920 (phone), 3179681162 (fax)
Education:
Medical School Univ Cattol De Sacro Cuore, Fac Di Med E Chirurgia, Roma, Italy Graduated: 1989
Procedures:
Chemotherapy
Conditions:
Bladder Cancer Dermatitis Erectile Dysfunction (ED) Kidney Cancer Prostate Cancer
Languages:
English
Description:
Dr. Pili graduated from the Univ Cattol De Sacro Cuore, Fac Di Med E Chirurgia, Roma, Italy in 1989. He works in Indianapolis, IN and specializes in Medical Oncology. Dr. Pili is affiliated with IU Health University Hospital.